• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多血管疾病对急性冠状动脉综合征患者长期预后的影响——意大利一项回顾性队列研究

Impact of Polyvascular Disease on Long-Term Prognosis of Patients with Acute Coronary Syndrome-A Retrospective Cohort Study in Italy.

作者信息

Mureddu Gian Francesco, Rosato Stefano, D'Errigo Paola, Faggiano Pompilio, Ciccarelli Paola, Badoni Gabriella, Ambrosetti Marco, Fattirolli Francesco, Baglio Giovanni

机构信息

Cardiac Rehabilitation Unit, San Giovanni-Addolorata Hospital, 00184 Rome, Italy.

ITACARE-P (Italian Alliance for Cardiovascular Rehabilitation and Prevention), 21100 Varese, Italy.

出版信息

J Clin Med. 2025 Jun 11;14(12):4158. doi: 10.3390/jcm14124158.

DOI:10.3390/jcm14124158
PMID:40565903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12194242/
Abstract

: Atherothrombosis is a systemic disease that may affect one or more than one vascular bed. Data on the impact of polyvascular disease (PVD) on the long-term prognosis of patients with coronary artery disease (CAD) are still scarce. Aim: To assess the prevalence of symptomatic PVD in a cohort of patients with a new episode of acute coronary syndrome (ACS) and to investigate the impact of multiple vascular beds involvement on long-term outcomes. : We analysed a nationwide, comprehensive administrative database of consecutive patients aged ≥ 40 years admitted for a new episode of ACS in Italy in 2017-2018. Patients with ACS were stratified according to the presence of peripheral artery disease (PAD) only; cerebrovascular disease (CeVD) only; PAD+CeVD; or neither (no PAD/noCeVD, i.e., ACS only). A multivariate Cox proportional hazards model was used to assess the impact of PAD only; CeVD only and PAD+CeVD on 5-year MACCE. : A total of 342,052 patients hospitalised with ACS were identified. Among them, 24,727 (7.2%) were patients with PAD only, 16,887 (4.9%) with CeVD only, and 5810 (1.7%) with PAD+CeVD. After adjusting for age, sex, and comorbidities, the hazard ratio (HR) for 5-year MACCE was 1.37 (95% CI: 1.35-1.40), 1.36 (95% CI: 1.33-1.39), and 1.45 (95% CI: 1.40-1.50) in patients with PAD only, CeVD only, and PAD+CeVD, respectively, compared with patients with ACS only. : In patients with ACS, the involvement of a second vascular bed increases the risk of long-term outcomes; the simultaneous involvement of three vascular beds further increases the risk of long-term outcomes.

摘要

动脉粥样硬化血栓形成是一种全身性疾病,可能影响一个或多个血管床。关于多血管疾病(PVD)对冠状动脉疾病(CAD)患者长期预后影响的数据仍然很少。目的:评估急性冠状动脉综合征(ACS)新发患者队列中有症状PVD的患病率,并研究多血管床受累对长期预后的影响。:我们分析了2017 - 2018年意大利全国范围内连续收治的≥40岁ACS新发患者的综合管理数据库。ACS患者仅根据外周动脉疾病(PAD)的存在情况进行分层;仅脑血管疾病(CeVD);PAD + CeVD;或两者都无(无PAD /无CeVD,即仅ACS)。使用多变量Cox比例风险模型评估仅PAD;仅CeVD和PAD + CeVD对5年主要不良心血管和脑血管事件(MACCE)的影响。:共确定了342,052例因ACS住院的患者。其中,仅PAD患者24,727例(7.2%),仅CeVD患者16,887例(4.9%),PAD + CeVD患者5810例(1.7%)。在调整年龄、性别和合并症后,仅PAD、仅CeVD和PAD + CeVD患者5年MACCE的风险比(HR)分别为1.37(95%置信区间:1.35 - 1.40)、1.36(95%置信区间:1.33 - 1.39)和1.45(95%置信区间:1.40 - 1.50),与仅ACS患者相比。:在ACS患者中,第二个血管床受累会增加长期预后风险;三个血管床同时受累会进一步增加长期预后风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad3/12194242/ae42b0e41d6f/jcm-14-04158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad3/12194242/8ea21e6f9643/jcm-14-04158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad3/12194242/0beb9ffec3cf/jcm-14-04158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad3/12194242/ae42b0e41d6f/jcm-14-04158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad3/12194242/8ea21e6f9643/jcm-14-04158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad3/12194242/0beb9ffec3cf/jcm-14-04158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad3/12194242/ae42b0e41d6f/jcm-14-04158-g003.jpg

相似文献

1
Impact of Polyvascular Disease on Long-Term Prognosis of Patients with Acute Coronary Syndrome-A Retrospective Cohort Study in Italy.多血管疾病对急性冠状动脉综合征患者长期预后的影响——意大利一项回顾性队列研究
J Clin Med. 2025 Jun 11;14(12):4158. doi: 10.3390/jcm14124158.
2
Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.腰交感神经切除术与前列腺素类药物治疗因不可重建的外周动脉疾病导致的严重肢体缺血的比较
Cochrane Database Syst Rev. 2018 Apr 16;4(4):CD009366. doi: 10.1002/14651858.CD009366.pub2.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Psychological and pharmacological interventions for depression in patients with coronary artery disease.冠心病患者抑郁的心理和药理学干预措施。
Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4.
8
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
9
Impact of Peripheral Arterial Disease on Outcomes of Acute Coronary Syndrome.外周动脉疾病对急性冠状动脉综合征结局的影响。
Maedica (Bucur). 2024 Sep;19(3):470-477. doi: 10.26574/maedica.2024.19.3.470.
10
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.非 ICU 住院患者预防谵妄的非药物干预措施。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013307. doi: 10.1002/14651858.CD013307.pub2.

本文引用的文献

1
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
2
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
3
Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease.
多血管受累在有症状外周动脉疾病患者中的预后作用
J Clin Med. 2023 May 11;12(10):3410. doi: 10.3390/jcm12103410.
4
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.140 万例经皮冠状动脉介入治疗患者的心脏外血管疾病对结局的影响。
Catheter Cardiovasc Interv. 2022 Nov;100(5):737-746. doi: 10.1002/ccd.30404. Epub 2022 Sep 21.
5
Impact of multisite artery disease on clinical outcomes after percutaneous coronary intervention: an analysis from the e-Ultimaster registry.多部位动脉疾病对经皮冠状动脉介入治疗后临床结局的影响:来自 e-Ultimaster 登记研究的分析。
Eur Heart J Qual Care Clin Outcomes. 2023 Jun 21;9(4):417-426. doi: 10.1093/ehjqcco/qcac043.
6
Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial.依洛尤单抗对所有血管区域的急性动脉事件的影响: FOURIER 试验的结果。
Eur Heart J. 2021 Dec 14;42(47):4821-4829. doi: 10.1093/eurheartj/ehab604.
7
The role of cardiac rehabilitation in improving cardiovascular outcomes.心脏康复在改善心血管结局中的作用。
Nat Rev Cardiol. 2022 Mar;19(3):180-194. doi: 10.1038/s41569-021-00611-7. Epub 2021 Sep 16.
8
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990—2019年全球、区域和国家的卒中负担及其风险因素:全球疾病负担研究2019的系统分析
Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
9
Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease.复杂冠状动脉疾病经冠状动脉血运重建后 10 年死亡的影响:已确立的心血管疾病的影响。
Clin Res Cardiol. 2021 Oct;110(10):1680-1691. doi: 10.1007/s00392-021-01922-y. Epub 2021 Aug 25.
10
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association.下肢外周动脉疾病:当代流行病学、管理差距与未来方向:美国心脏协会科学声明。
Circulation. 2021 Aug 31;144(9):e171-e191. doi: 10.1161/CIR.0000000000001005. Epub 2021 Jul 28.